Glenmark Life Sciences Ltd. IPO — GMP, Details & Subscription

IPO Details

Open Date

27 Jul 2021

Close Date

29 Jul 2021

Allotment

03 Aug 2021

Listing Date

06 Aug 2021

Exchange

NSE & BSE

Price Band

₹720

Listing Price

See chart

Allotment Status

Check Now →

Price Band

₹720

Per share

Face Value

₹2 per share

Lot Size

20 Shares

per lot

Issue Size

2,10,22,222 shares (aggregating up to ₹1,513.60 Cr)

Total offering

Issue Type

Bookbuilding IPO

Min Investment

₹14,400

1 lot

Pre-IPO Holding

10,78,04,950 shares

Promoters

Post-IPO Holding

12,25,27,172 shares

Promoters

UPI Deadline

2021-07-29

Mandate

Anchor AllotmentMon, 26 Jul 2021

Basis of AllotmentTue, 03 Aug 2021

Refund InitiationWed, 04 Aug 2021

Demat CreditThu, 05 Aug 2021

Listing DayFri, 06 Aug 2021

UPI Mandate Deadline2021-07-29

Sale TypeFresh Capital-cum-Offer for Sale

Fresh Issue Shares1,47,22,222 shares (aggregating up to ₹1,060.00 Cr)

Offer for Sale63,00,000 shares of ₹2 (aggregating up to ₹453.60 Cr)

QIB Quota50% of Net Issue

HNI / NII Quota15% of Net Issue

Retail Quota35% of Net Issue

Check AllotmentClick here →

Subscription Rate Final

Glenmark Life Sciences Ltd. IPO subscribed 1.00 times overall. Retail: 1.00x. QIB: 1.00x. NII: 1.00x. By 29 Jul 2021.

QIB

1.00x

Over

NII/HNI

1.00x

Over

Retail

1.00x

Over

Total

1.00x

Over

Category	Subscription	Shares Offered	% of Total	Amount (₹Cr)
QIB	Over 1.00x	—	—	—
NII / HNI	Over 1.00x	—	—	—
Retail	Over 1.00x	—	—	—
Total	1.00x	21,022,222	100%	₹1,513.60

IPO Shares Offered

Glenmark Life Sciences Ltd. IPO total issue size: ₹1,513.60 Cr.

Category	Shares Offered	Amount (₹Cr)	Size (%)
Total	21,022,222	₹1,513.60	100.00%

* Based on upper price band ₹720 per share

Lot Size & Investment

Lot Size

Shares per Lot

Issue Price

₹720.00

Upper Band

Min Investment

₹14,400

1 Lot

Application	Lots	Shares	Amount
Retail (Min — 2 Lots)	2	40	₹28,800
Retail (Max — 13 Lots)	13	260	₹187,200
S-HNI (Min — 14 Lots)	14	280	₹201,600
B-HNI (Min — 70 Lots)	70	1,400	₹1,008,000

* Issue Price ₹720 × Lot Size 20 shares

IPO Schedule

Anchor

26 Jul 2021

✓ Done

IPO Open

27 Jul 2021

✓ Done

IPO Close

29 Jul 2021

✓ Done

Allotment

03 Aug 2021

✓ Done

Refunds

04 Aug 2021

✓ Done

Demat Credit

05 Aug 2021

✓ Done

Listing Day

06 Aug 2021

✓ Done

₹720.00

INR · BSE

Fetching…

vs Issue Price

—

OPEN

—

HIGH

—

LOW

—

MKT CAP

—

P/E

—

52W HIGH

—

52W LOW

—

VOLUME

—

DIVIDEND

—

DIV YIELD

—

Loading…

Chart Not Available

Try again 2–3 days after listing.

Issue ₹720.00 Live Price

About Glenmark Life Sciences Ltd.

Incorporated in 2011, Glenmark Life Sciences is the leading manufacturer of Active Pharmaceutical Ingredients (APIs). The company develops, manufactures, and supplies high-quality APIs for cardiovascular disease (CVS), central nervous system disease (CNS), pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas. It further operates in Contract Development and manufacturing operations (CDMO) to offer services to specialty Pharmaceutical companies.Its products are being sold in India and also expoted to multiple countries i.e. Europe, North America, Latin America, Japan, etc. Currently, it has 4 manufacturing facilities at Ankleshwar and Dahej in Gujarat and Mohol and Kurkumbh in Maharashtra State with an aggregate annual installed capacity of 725.8 KL as of December 31, 2020.Competitive strengthsLeading manufacturer of selected specialized APIs for chronic therapeutic areas like CVS, CNS, diabetes, and pain management.Export products in Europe, Latin America, North America, Japan, and the rest of the world.Strong relationship with leading global generic companies.Proven track record of strong financial performance.High-quality product manufacturing with R&D infrastructure.

Objects of the Issue

1 Payment of outstanding purchase consideration to the Promoter for thespin-off of the API business from the Promoter into our Companypursuant to the Business Purchase Agreementdated October 9, 2018

2 Funding the capital expenditure requirements

3 General corporate purposes

Glenmark Life Sciences Ltd. Financials (Amount in Crore)

Revenue from Operations

₹886.9

31-Mar-19

₹1,549.3

31-Mar-20

₹1,886.0

31-Mar-21

Profit After Tax (PAT)

₹195.6

31-Mar-19

₹313.1

31-Mar-20

₹351.6

31-Mar-21

Particulars	31-Mar-21	31-Mar-20	31-Mar-19
Revenue from Operations	1885.98	1549.30	886.87
EBITDA	N/A	N/A	N/A
Profit After Tax (PAT)	351.58	313.10	195.59
Net Worth	N/A	N/A	N/A
Total Assets	1997.08	1725.60	1475.40
Reserves & Surplus	N/A	N/A	N/A
Borrowings	N/A	N/A	N/A
EBITDA Margin (%)	N/A	—	—
PAT Margin (%)	N/A	—	—

Issue Structure & Shareholding

Total Shares Offered2,10,22,222 (100.00%)

Net Offer to PublicN/A

Reserved for Market MakerN/A

Pre-Issue Promoter Holding10,78,04,950 shares

Post-Issue Promoter Holding12,25,27,172 shares

P/BV RatioN/A

RoEN/A

RoCEN/A

Debt / EquityN/A

Script CodeN/A

Registrar & Lead Managers

IPO Registrar

Kfin Technologies Ltd.

04067162222, 04079611000

glenmark.ipo@kfintech.com

https://ipostatus.kfintech.com/

Check Allotment

Book Running Lead Managers

BOFA Securities India Ltd.

BOB Capital Markets Ltd.

Dam Capital Advisors Ltd.

Goldman Sachs (India) Securities Pvt.Ltd.

Kotak Mahindra Capital Co.Ltd.

SBI Capital Markets Ltd.

GMP Disclaimer: Grey Market Premium data is unofficial and unregulated. It does not guarantee actual listing price.

IPO Subscription FAQs

How much Glenmark Life Sciences Ltd. IPO subscribed? ▲

Glenmark Life Sciences Ltd. IPO is subscribed 1.00 times by Jul 29, 2021. Retail: 1.00x. QIB: 1.00x. NII: 1.00x.

Investor Category	Subscription
Qualified Institutional (QIB)	1.00x
Non Institutional (NII/HNI)	1.00x
Retail Individual	1.00x
Total Subscription	1.00x

What is Glenmark Life Sciences Ltd. IPO retail subscription status? ▼

The Glenmark Life Sciences Ltd. IPO retail category is subscribed 1.00 times as of 29 Jul 2021. The retail portion is oversubscribed.

How to subscribe Glenmark Life Sciences Ltd. IPO? ▼

Subscribe via your broker app using ASBA or UPI. Opens 27 Jul 2021 and closes 29 Jul 2021. Min investment: ₹14,400 (1 lot = 20 shares). UPI mandate: 2021-07-29.

How many times Glenmark Life Sciences Ltd. IPO subscribed? ▼

The Glenmark Life Sciences Ltd. IPO subscribed 1.00x overall. QIB: 1.00x, NII: 1.00x, Retail: 1.00x. Applications: from NSE/BSE.

How to check Glenmark Life Sciences Ltd. IPO allotment? ▼

Check allotment on the registrar website (Kfin Technologies Ltd.) at https://ipostatus.kfintech.com/. Enter your PAN, application number or DP/Client ID. Allotment date: 03 Aug 2021. Refunds: on 04 Aug 2021.

When Glenmark Life Sciences Ltd. IPO will be listed? ▼

The Glenmark Life Sciences Ltd. IPO listing date is 06 Aug 2021, Friday. Listed on: NSE & BSE. Issue price: ₹720. Estimated listing: ₹720. GMP: NIL.

When Glenmark Life Sciences Ltd. IPO close? ▼

The Glenmark Life Sciences Ltd. IPO closes on 29 Jul 2021, Thursday. UPI mandate: 2021-07-29. Allotment: 03 Aug 2021. Listing: 06 Aug 2021.

Quick Actions

Check Allotment

Live Price LIVE

Last Price₹720.00

Change—

Issue Price₹720.00

vs Issue—

Quick Summary

StatusListed

Issue Price₹720

Face Value₹2

Lot Size20 Sh

Min. Amount₹14,400

GMPNIL

Est. Listing₹720

Subscribed1.00x

Open Date27 Jul 2021

Close Date29 Jul 2021

Allotment03 Aug 2021

Listing Date06 Aug 2021

ExchangeNSE & BSE

UPI Deadline2021-07-29